Literature DB >> 26195516

Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland.

Sarah C Schneider1, Regula Tinguely1, Sara Droz1, Markus Hilty2, Valentina Donà1, Thomas Bodmer3, Andrea Endimiani4.   

Abstract

Antibiotic resistance in Ureaplasma urealyticum/Ureaplasma parvum and Mycoplasma hominis is an issue of increasing importance. However, data regarding the susceptibility and, more importantly, the clonality of these organisms are limited. We analyzed 140 genital samples obtained in Bern, Switzerland, in 2014. Identification and antimicrobial susceptibility tests were performed by using the Mycoplasma IST 2 kit and sequencing of 16S rRNA genes. MICs for ciprofloxacin and azithromycin were obtained in broth microdilution assays. Clonality was analyzed with PCR-based subtyping and multilocus sequence typing (MLST), whereas quinolone resistance and macrolide resistance were studied by sequencing gyrA, gyrB, parC, and parE genes, as well as 23S rRNA genes and genes encoding L4/L22 ribosomal proteins. A total of 103 samples were confirmed as positive for U. urealyticum/U. parvum, whereas 21 were positive for both U. urealyticum/U. parvum and M. hominis. According to the IST 2 kit, the rates of nonsusceptibility were highest for ciprofloxacin (19.4%) and ofloxacin (9.7%), whereas low rates were observed for clarithromycin (4.9%), erythromycin (1.9%), and azithromycin (1%). However, inconsistent results between microdilution and IST 2 kit assays were recorded. Various sequence types (STs) observed previously in China (ST1, ST2, ST4, ST9, ST22, and ST47), as well as eight novel lineages, were detected. Only some quinolone-resistant isolates had amino acid substitutions in ParC (Ser83Leu in U. parvum of serovar 6) and ParE (Val417Thr in U. parvum of serovar 1 and the novel Thr417Val substitution in U. urealyticum). Isolates with mutations in 23S rRNA or substitutions in L4/L22 were not detected. This is the first study analyzing the susceptibility of U. urealyticum/U. parvum isolates in Switzerland and the clonality outside China. Resistance rates were low compared to those in other countries. We hypothesize that some hyperepidemic STs spread worldwide via sexual intercourse. Large combined microbiological and clinical studies should address this important issue.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26195516      PMCID: PMC4576132          DOI: 10.1128/AAC.00895-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.

Authors:  Yasuhiro Kawai; Yukiko Nakura; Tetsu Wakimoto; Makoto Nomiyama; Tsugumichi Tokuda; Toshimitsu Takayanagi; Jun Shiraishi; Kenshi Wasada; Hiroyuki Kitajima; Tomio Fujita; Masahiro Nakayama; Nobuaki Mitsuda; Isao Nakanishi; Makoto Takeuchi; Itaru Yanagihara
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.

Authors:  Michael L Beeton; Victoria J Chalker; Sailesh Kotecha; O Brad Spiller
Journal:  J Antimicrob Chemother       Date:  2009-06-30       Impact factor: 5.790

3.  Analysis of the quinolone-resistance determining region of the gyrA gene and the analogous region of the parC gene in Ureaplasma parvum and Ureaplasma urealyticum detected in first-void urine of men with non-gonococcal urethritis.

Authors:  Yasuyoshi Kamiya; Yasushi Shimada; Shin Ito; Mina Kikuchi; Mitsuru Yasuda; Yoshiaki Kawamura; Takashi Deguchi
Journal:  J Antimicrob Chemother       Date:  2012-10-22       Impact factor: 5.790

4.  Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.

Authors:  S Pereyre; M Métifiot; C Cazanave; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Int J Antimicrob Agents       Date:  2006-12-28       Impact factor: 5.283

5.  In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.

Authors:  C M Bebear; H Renaudin; A Charron; D Gruson; M Lefrancois; C Bebear
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

6.  Antibiotic susceptibilities and resistance genes of Ureaplasma parvum isolated in South Africa.

Authors:  S Govender; K Gqunta; M le Roux; B de Villiers; L J Chalkley
Journal:  J Antimicrob Chemother       Date:  2012-08-09       Impact factor: 5.790

7.  Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.

Authors:  Michael L Beeton; Victoria J Chalker; Nicola C Maxwell; Sailesh Kotecha; O Brad Spiller
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

8.  Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum.

Authors:  Meng Dongya; Xue Wencheng; Ma Xiaobo; Wang Lu
Journal:  Microb Drug Resist       Date:  2008-09       Impact factor: 3.431

9.  Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013.

Authors:  Qing-Yong Wang; Rong-Hai Li; Lu-Qing Zheng; Xiao-Hong Shang
Journal:  J Microbiol Immunol Infect       Date:  2014-07-28       Impact factor: 4.399

10.  Correlation between Ureaplasma subgroup 2 and genitourinary tract disease outcomes revealed by an expanded multilocus sequence typing (eMLST) scheme.

Authors:  Jun Zhang; Yingying Kong; Zhi Ruan; Jun Huang; Tiejun Song; Jingjuan Song; Yan Jiang; Yunsong Yu; Xinyou Xie
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more
  9 in total

1.  Prevalence and antimicrobial resistance of Ureaplasma spp. and Mycoplasma hominis isolated from semen samples of infertile men in Shanghai, China from 2011 to 2016.

Authors:  Y-H Zhou; H-X Ma; Y Yang; W-M Gu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-08       Impact factor: 3.267

2.  Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States.

Authors:  Javier Fernández; Melissa J Karau; Scott A Cunningham; Kerryl E Greenwood-Quaintance; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

3.  Antimicrobial resistance in clinical isolates of Ureaplasma spp. from samples in Germany.

Authors:  Roger Dumke
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.191

4.  Antimicrobial Resistance in Clinical Ureaplasma spp. and Mycoplasma hominis and Structural Mechanisms Underlying Quinolone Resistance.

Authors:  Ting Yang; Lianlian Pan; Ningning Wu; Lin Wang; Zhen Liu; Yingying Kong; Zhi Ruan; Xinyou Xie; Jun Zhang
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

5.  Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.

Authors:  Michael L Beeton; Victoria J Chalker; Lucy C Jones; Nicola C Maxwell; O Brad Spiller
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

6.  An Observational Study: Is N-Acetylcysteine Helpful in Performance Improvement of Mycoplasma IST2 Testing through Sample Homogenization?

Authors:  Xin-Ru Mao; Rui-Cheng Wang; Rong-Jiao Li; Cai-Rong Zhou; Xian-Kai Chen; Can-Can Cheng; Xiao-Mao Yin
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-07-02       Impact factor: 2.471

7.  Prevalence and antibiotic resistance of rectal Mollicutes in HIV-infected men who have sex with men at the University Hospital of Dresden, Germany.

Authors:  Petra Spornraft-Ragaller; Roger Dumke
Journal:  Infection       Date:  2020-01-28       Impact factor: 3.553

8.  Clinical and Microbiological Characterization of Bloodstream Infections Caused by Mycoplasma hominis: An Overlooked Pathogen.

Authors:  Tong Zeng; Yuan Wu; Zhiyu Yang; Min Luo; Chang Xu; Zhuoran Liu; Jinglin Ouyang; Logen Liu; Xiaotuan Zhang
Journal:  Infect Dis Ther       Date:  2022-03-14

9.  Clonality and distribution of clinical Ureaplasma isolates recovered from male patients and infertile couples in China.

Authors:  Zhi Ruan; Ting Yang; Xinyan Shi; Yingying Kong; Xinyou Xie; Jun Zhang
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.